Medical research

Why remdesivir does not fully stop the coronavirus

Remdesivir is the first drug against COVID-19 to be conditionally approved in Europe and the United States. The drug is designed to suppress the rapid replication of the SARS-CoV-2 virus in human cells by blocking the viral ...

Diseases, Conditions, Syndromes

How coronavirus took hold in North America and in Europe

A new study combines evolutionary genomics from coronavirus samples with computer-simulated epidemics and detailed travel records to reconstruct the spread of coronavirus across the world in unprecedented detail.

Diseases, Conditions, Syndromes

How the new coronavirus penetrates, exploits and kills cells

"Know your enemy," Sun Tzu, the great sage of war, wrote some 2,500 years ago. Today, as COVID-19 spreads around the globe, the greatest army of medical scientists ever assembled is bent on learning all it can, as fast as ...

Diseases, Conditions, Syndromes

Researchers discover new pathways that could help treat RNA viruses

Researchers at the University of New Hampshire have identified new pathways in an RNA-based virus where inhibitors, like medical treatments, unbind. The finding could be beneficial in understanding how these inhibitors react ...

page 1 from 8